Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathogenic Th2 Cytokine Profile Skewing by IFN-γ-Responding Vitiligo Fibroblasts via CCL2/CCL8
Rong Jin, Miaoni Zhou, Fuquan Lin, et al.
Cells (2023) Vol. 12, Iss. 2, pp. 217-217
Open Access | Times Cited: 19

Showing 19 citing articles:

Combination of Baricitinib and Phototherapy in Adults With Active Vitiligo
Julien Séneschal, Mathilde Guyon, Ribal Merhi, et al.
JAMA Dermatology (2025)
Closed Access | Times Cited: 1
Mitophagy and immune infiltration in vitiligo: evidence from bioinformatics analysis
Lingling Luo, Jing Zhu, Youming Guo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
The role of dermal fibroblasts in autoimmune skin diseases
Zeqi Shi, Zhong Liu, Yujia Wei, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Treatment update for vitiligo based on autoimmune inhibition and melanocyte protection
Bo Xie, Yuqi Zhu, Yuqing Shen, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 3, pp. 189-206
Closed Access | Times Cited: 11
Resident memory T cells in nonlesional skin and healed lesions of patients with chronic inflammatory diseases: Appearances can be deceptive
Laure Migayron, Ribal Merhi, Julien Séneschal, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 153, Iss. 3, pp. 606-614
Closed Access | Times Cited: 11
Fibroblast: A Novel Target for Autoimmune and Inflammatory Skin Diseases Therapeutics
Xiaoyun Chen, Yutong Wu, Sujie Jia, et al.
Clinical Reviews in Allergy & Immunology (2024) Vol. 66, Iss. 3, pp. 274-293
Closed Access | Times Cited: 3
A Mendelian randomization study on the causal effects of circulating cytokines on the risk of vitiligo
Chengling Liu, Xingchen Liu, Haiming Xin, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2
Early short-term hypoxia promotes epidermal cell migration by activating the CCL2-ERK1/2 pathway and epithelial–mesenchymal transition during wound healing
Linbo Jin, Shiqi Zhou, Shihan Zhao, et al.
Burns & Trauma (2024) Vol. 12
Open Access | Times Cited: 2
1,25-Dihydroxyvitamin D3 Provides Benefits in Vitiligo Based on Modulation of CD8+ T Cell Glycolysis and Function
Yujia Wei, Tingmei Wang, Xiaoqi Nie, et al.
Nutrients (2023) Vol. 15, Iss. 21, pp. 4697-4697
Open Access | Times Cited: 6
JAK Inhibitors in Immune Regulation and Treatment of Vitiligo
Kewei Liu, Linyi Zhou, Meihui Shi, et al.
Cytokine & Growth Factor Reviews (2024) Vol. 80, pp. 87-96
Closed Access | Times Cited: 1
Unraveling the causal associations between systemic cytokines and six inflammatory skin diseases
Waner Liu, Xu Zhang, Xiang Chen
Cytokine (2024) Vol. 185, pp. 156810-156810
Closed Access | Times Cited: 1
Biologic drugs induced vitiligo: case reports and review of literature
Xinyi Shao, Tingqiao Chen, Xingyu Pan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Evaluation of CAT Variants A-89T, C389T, and C419T in Patients with Vitiligo in the Saudi Population
Ghada A. Bin Saif, Amal F. Alshammary, Imran Ali Khan
Medicina (2023) Vol. 59, Iss. 4, pp. 708-708
Open Access | Times Cited: 2
A comparative study of narrow-band ultraviolet B alone versus with low dose simvastatin in the treatment of vitiligo: impact on chemokine C-X-C motif ligand 10 and chemokine C–C motif ligand 8
Shaimaa Ismail Omar, Adel El Shafey, Nermeen Eldabah, et al.
Journal of the Egyptian Womenʼs Dermatologic Society (2024) Vol. 21, Iss. 3, pp. 213-221
Open Access
Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
Laure Migayron, Sylvie Bordes, B. Closs, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Role of fibroblasts in nonfibrotic autoimmune skin diseases
Yuexi He, Zhiying Han, Qiuli Zhang, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access
Exploring mechanisms of skin aging: insights for clinical treatment
Meiqi Zhang, Yumeng Lin, Zhongyu Han, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Aetiopathogenesis of Vitiligo
Katia Boniface
Dermatology Practical & Conceptual (2023), pp. e2023314S-e2023314S
Open Access | Times Cited: 1
JAK inhibitors in vitiligo: what they hit and what they miss - an immunopathogenesis based exposition of existing evidence
Kabir Sardana, Aishwarya Muddebihal, Ananta Khurana
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 12, pp. 1221-1227
Closed Access
Page 1

Scroll to top